{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:16:21Z","timestamp":1790727381620,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:00:00Z","timestamp":1437609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/bjc.2015.258","type":"journal-article","created":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T22:46:37Z","timestamp":1437691597000},"page":"603-610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer"],"prefix":"10.1038","volume":"113","author":[{"given":"J","family":"Rees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C N","family":"Hurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gollins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Maughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S J","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Staffurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J I","family":"Geh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Bridgewater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L S","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Blazeby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Crosby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"key":"BFbjc2015258_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"N Aaronson","year":"1993","unstructured":"Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N, Filiberti A, Flechtner H, Fleishman S, de Haes J, Kaasa S, Klee M, Rofe P, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365\u2013376.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"BFbjc2015258_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ijrobp.2009.02.086","volume":"75","author":"H Ariga","year":"2009","unstructured":"Ariga H, Nemoto K, Miyazaki S, Yoshioka T, Ogawa Y, Sakayauchi T, Jingu K, Miyata G, Onodera K, Ichikawa H, Kamei T, Kato S, Ishioka C, Satomi S, Yamada S (2009) Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 75 (2): 348\u2013356.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"BFbjc2015258_CR3","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/bjs.5888","volume":"94","author":"KN Avery","year":"2007","unstructured":"Avery KN, Metcalfe C, Barham CP, Alderson D, Falk SJ, Blazeby JM (2007) Quality of life during potentially curative treatment for locally advanced oesophageal cancer. Br J Surg 94 (11): 1369\u20131376.","journal-title":"Br J Surg"},{"issue":"5","key":"BFbjc2015258_CR4","first-page":"997","volume":"159","author":"MK Basra","year":"2008","unstructured":"Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY (2008) The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 159 (5): 997\u20131035.","journal-title":"Br J Dermatol"},{"issue":"10","key":"BFbjc2015258_CR5","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","volume":"25","author":"L Bedenne","year":"2007","unstructured":"Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, Paillot B, Arveux P, Bonnetain F, Binquet C (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25 (10): 1160\u20131168.","journal-title":"J Clin Oncol"},{"key":"BFbjc2015258_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-3-642-59600-1_20","volume":"155","author":"JM Blazeby","year":"2000","unstructured":"Blazeby JM, Alderson D, Farndon JR (2000) Quality of life in patients with oesophageal cancer. Recent Results Cancer Res 155: 193\u2013204.","journal-title":"Recent Results Cancer Res"},{"issue":"10","key":"BFbjc2015258_CR7","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/S0959-8049(03)00270-3","volume":"39","author":"JM Blazeby","year":"2003","unstructured":"Blazeby JM, Conroy T, Hammerlid E, Fayers P, Sezer O, Koller M, Arraras J, Bottomley A, Vickery CW, Etienne PL, Alderson D European Organisation for R Treatement of Cancer G Quality of Life G (2003) Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39 (10): 1384\u20131394.","journal-title":"Eur J Cancer"},{"issue":"9","key":"BFbjc2015258_CR8","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/cncr.20980","volume":"103","author":"JM Blazeby","year":"2005","unstructured":"Blazeby JM, Sanford E, Falk SJ, Alderson D, Donovan JL (2005) Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma. Cancer 103 (9): 1791\u20131799.","journal-title":"Cancer"},{"issue":"2","key":"BFbjc2015258_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/bjc.2014.313","volume":"111","author":"JM Blazeby","year":"2014","unstructured":"Blazeby JM, Strong S, Donovan JL, Wilson C, Hollingworth W, Crosby T, Nicklin J, Falk SJ, Barham CP, Hollowood AD, Streets CG, Titcomb D, Krysztopik R, Griffin SM, Brookes ST (2014) Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer. Br J Cancer 111 (2): 234\u2013240.","journal-title":"Br J Cancer"},{"issue":"8","key":"BFbjc2015258_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jama.2013.879","volume":"309","author":"M Calvert","year":"2013","unstructured":"Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD CONSORT PRO Group (2013) Reporting of patient-reported outcomes in randomized trials: The consort pro extension. JAMA 309 (8): 814\u2013822.","journal-title":"JAMA"},{"issue":"3","key":"BFbjc2015258_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1470-2045(14)70028-2","volume":"15","author":"T Conroy","year":"2014","unstructured":"Conroy T, Galais M-P, Raoul J-L, Bouch\u00e9 O, Gourgou-Bourgade S, Douillard J-Y, Etienne P-L, Boige V, Martel-Lafay I, Michel P, Llacer-Moscardo C, Fran\u00e7ois E, Cr\u00e9hange G, Abdelghani MB, Juzyna B, Bedenne L, Adenis A (2014) Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5\/ACCORD17): final results of a randomised, phase 2\/3 trial. Lancet Oncol 15 (3): 305\u2013314.","journal-title":"Lancet Oncol"},{"issue":"7","key":"BFbjc2015258_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1470-2045(13)70136-0","volume":"14","author":"T Crosby","year":"2013","unstructured":"Crosby T, Hurt CN, Falk S, Gollins S, Mukherjee S, Staffurth J, Ray R, Bashir N, Bridgewater JA, Geh JI, Cunningham D, Blazeby J, Roy R, Maughan T, Griffiths G (2013) Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2\/3 randomised trial. Lancet Oncol 14 (7): 627\u2013637.","journal-title":"Lancet Oncol"},{"issue":"1","key":"BFbjc2015258_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ the MAGIC Trial Participants (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (1): 11\u201320.","journal-title":"N Engl J Med"},{"issue":"14","key":"BFbjc2015258_CR14","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1200\/JCO.2011.40.3568","volume":"30","author":"M Derogar","year":"2012","unstructured":"Derogar M, Orsini N, Sadr-Azodi O, Lagergren P (2012) Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. J Clin Oncol 30 (14): 1615\u20131619.","journal-title":"J Clin Oncol"},{"key":"BFbjc2015258_CR15","volume-title":"EORTC QLQ-C30 Scoring Manual","author":"P Fayers","year":"2002","unstructured":"Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A (2002) EORTC QLQ-C30 Scoring Manual 2nd edn. EORTC Publications: Brussels, Belgium."},{"issue":"3","key":"BFbjc2015258_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol 19 (3): 210\u2013216.","journal-title":"Clin Exp Dermatol"},{"key":"BFbjc2015258_CR17","unstructured":"Food and Drug Administration (2009) Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to support Labeling Claims. Food and Drug Administration, US Department of Health and Human Services: Rockville, MD, USA."},{"issue":"3","key":"BFbjc2015258_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","volume":"8","author":"V Gebski","year":"2007","unstructured":"Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8 (3): 226\u2013234.","journal-title":"Lancet Oncol"},{"issue":"3","key":"BFbjc2015258_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.clon.2007.12.002","volume":"20","author":"CM Gillham","year":"2008","unstructured":"Gillham CM, Aherne N, Rowley S, Moore J, Hollywood D, O'Byrne K, Reynolds JV (2008) Quality of life and survival in patients treated with radical chemoradiation alone for oesophageal cancer. Clin Oncol (R Coll Radiol) 20 (3): 227\u2013233.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"BFbjc2015258_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/1471-2407-11-466","volume":"11","author":"CN Hurt","year":"2011","unstructured":"Hurt CN, Nixon LS, Griffiths GO, Al-Mokhtar R, Gollins S, Staffurth JN, Phillips CJ, Blazeby JM, Crosby TD (2011) SCOPE1: a randomised phase II\/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus. BMC Cancer 11: 466.","journal-title":"BMC Cancer"},{"issue":"7","key":"BFbjc2015258_CR21","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s11136-012-0290-8","volume":"22","author":"M Jacobs","year":"2012","unstructured":"Jacobs M, Macefield RC, Blazeby JM, Korfage IJ, van Berge Henegouwen MI, de Haes HC, Smets EM, Sprangers MA (2012) Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer. Qual Life Res 22 (7): 1787\u20131803.","journal-title":"Qual Life Res"},{"issue":"7","key":"BFbjc2015258_CR22","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s11136-012-0290-8","volume":"22","author":"M Jacobs","year":"2013","unstructured":"Jacobs M, Macefield RC, Blazeby JM, Korfage IJ, van Berge Henegouwen MI, de Haes HC, Smets EM, Sprangers MA (2013) Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer. Qual Life Res 22 (7): 1787\u20131803.","journal-title":"Qual Life Res"},{"issue":"4","key":"BFbjc2015258_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s11136-013-0576-5","volume":"23","author":"M Jacobs","year":"2014","unstructured":"Jacobs M, Macefield RC, Elbers RG, Sitnikova K, Korfage IJ, Smets EMA, Henselmans I, van Berge Henegouwen MI, de Haes JCJM, Blazeby JM, Sprangers MAG (2014) Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery. Qual Life Res 23 (4): 1155\u20131176.","journal-title":"Qual Life Res"},{"issue":"2","key":"BFbjc2015258_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61 (2): 69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"BFbjc2015258_CR25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/bjs.7455","volume":"98","author":"M Kranzfelder","year":"2011","unstructured":"Kranzfelder M, Schuster T, Geinitz H, Friess H, Buchler P (2011) Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Br J Surg 98 (6): 768\u2013783.","journal-title":"Br J Surg"},{"issue":"10","key":"BFbjc2015258_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa010187","volume":"345","author":"JS Macdonald","year":"2001","unstructured":"Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (10): 725\u2013730.","journal-title":"N Engl J Med"},{"key":"BFbjc2015258_CR27","first-page":"CD001556","volume":"3","author":"RA Malthaner","year":"2006","unstructured":"Malthaner RA, Collin S, Fenlon D (2006) Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev 3: CD001556.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9319","key":"BFbjc2015258_CR28","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","volume":"359","author":"MRC Oesophageal Cancer Working Party","year":"2002","unstructured":"MRC Oesophageal Cancer Working Party (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359 (9319): 1727\u20131733.","journal-title":"Lancet"},{"issue":"1","key":"BFbjc2015258_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16 (1): 139\u2013144.","journal-title":"J Clin Oncol"},{"issue":"4","key":"BFbjc2015258_CR30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/bjs.6908","volume":"97","author":"R Parameswaran","year":"2010","unstructured":"Parameswaran R, Blazeby JM, Hughes R, Mitchell K, Berrisford RG, Wajed SA (2010) Health-related quality of life after minimally invasive oesophagectomy. Br J Surg 97 (4): 525\u2013531.","journal-title":"Br J Surg"},{"issue":"9","key":"BFbjc2015258_CR31","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1245\/s10434-008-0042-8","volume":"15","author":"R Parameswaran","year":"2008","unstructured":"Parameswaran R, McNair A, Avery KN, Berrisford RG, Wajed SA, Sprangers MA, Blazeby JM (2008) The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review. Ann Surg Oncol 15 (9): 2372\u20132379.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"BFbjc2015258_CR32","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2011.38.6177","volume":"30","author":"JR Rees","year":"2012","unstructured":"Rees JR, Blazeby JM, Fayers P, Friend EA, Welsh FK, John TG, Rees M (2012) Patient-reported outcomes after hepatic resection of colorectal cancer metastases. J Clin Oncol 30 (12): 1364\u20131370.","journal-title":"J Clin Oncol"},{"issue":"9","key":"BFbjc2015258_CR33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/bjs.5373","volume":"93","author":"JV Reynolds","year":"2006","unstructured":"Reynolds JV, McLaughlin R, Moore J, Rowley S, Ravi N, Byrne PJ (2006) Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg 93 (9): 1084\u20131090.","journal-title":"Br J Surg"},{"issue":"15","key":"BFbjc2015258_CR34","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1016\/j.ejca.2013.05.029","volume":"49","author":"U Ronellenfitsch","year":"2013","unstructured":"Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Kieser M, Slanger TE, Burmeister B, Kelsen D, Niedzwiecki D, Schuhmacher C, Urba S, van de Velde C, Walsh TN, Ychou M, Jensen K (2013a) Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data. Eur J Cancer 49 (15): 3149\u20133158.","journal-title":"Eur J Cancer"},{"key":"BFbjc2015258_CR35","first-page":"CD008107","volume":"5","author":"U Ronellenfitsch","year":"2013","unstructured":"Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Kieser M, Slanger TE, Jensen K Group GEAM-a (2013b) Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus. Cochrane Database Syst Rev 5: CD008107.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"BFbjc2015258_CR36","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","volume":"26","author":"J Tepper","year":"2008","unstructured":"Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D, Mayer R (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26 (7): 1086\u20131092.","journal-title":"J Clin Oncol"},{"key":"BFbjc2015258_CR37","first-page":"CD002092","volume":"1","author":"R Wong","year":"2006","unstructured":"Wong R, Malthaner R (2006) Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 1: CD002092.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"BFbjc2015258_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/jso.21361","volume":"100","author":"H Yamashita","year":"2009","unstructured":"Yamashita H, Okuma K, Seto Y, Mori K, Kobayashi S, Wakui R, Ohtomo K, Nakagawa K (2009a) A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma. J Surg Oncol 100 (6): 435\u2013441.","journal-title":"J Surg Oncol"},{"issue":"6","key":"BFbjc2015258_CR39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/jso.21361","volume":"100","author":"H Yamashita","year":"2009","unstructured":"Yamashita H, Okuma K, Seto Y, Mori K, Kobayashi S, Wakui R, Ohtomo K, Nakagawa K (2009b) A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II\u2013III esophageal carcinoma. J Surg Oncol 100 (6): 435\u2013441.","journal-title":"J Surg Oncol"},{"issue":"13","key":"BFbjc2015258_CR40","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","volume":"29","author":"M Ychou","year":"2011","unstructured":"Ychou M, Boige V, Pignon JP, Conroy T, Bouche O, Lebreton G, Ducourtieux M, Bedenne L, Fabre JM, Saint-Aubert B, Geneve J, Lasser P, Rougier P (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29 (13): 1715\u20131721.","journal-title":"J Clin Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2015258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2015258","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2015258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:29:31Z","timestamp":1684416571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2015258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFbjc2015258"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2015.258","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,23]]},"assertion":[{"value":"3 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}